151 related articles for article (PubMed ID: 1706235)
1. Expression of decay-accelerating factor is reduced on hyperplastic synovial lining cells in rheumatoid synovitis.
Itoh J; Nose M; Fujita T; Kato M; Ohyama A; Kyogoku M
Clin Exp Immunol; 1991 Mar; 83(3):364-8. PubMed ID: 1706235
[TBL] [Abstract][Full Text] [Related]
2. Expression of decay-accelerating factor on synovial lining cells in inflammatory and degenerative arthritides.
Tarkowski A; Trollmo C; Seifert PS; Hansson GK
Rheumatol Int; 1992; 12(5):201-5. PubMed ID: 1283924
[TBL] [Abstract][Full Text] [Related]
3. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
[TBL] [Abstract][Full Text] [Related]
4. Expression of molecules involved in B lymphocyte survival and differentiation by synovial fibroblasts.
Edwards JC; Leigh RD; Cambridge G
Clin Exp Immunol; 1997 Jun; 108(3):407-14. PubMed ID: 9182884
[TBL] [Abstract][Full Text] [Related]
5. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy.
Baeten D; Kruithof E; De Rycke L; Boots AM; Mielants H; Veys EM; De Keyser F
Arthritis Res Ther; 2005; 7(2):R359-69. PubMed ID: 15743484
[TBL] [Abstract][Full Text] [Related]
6. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis.
Rittner HL; Zettl A; Jendro MC; Bartz-Bazzanella P; Goronzy JJ; Weyand CM
Mol Med; 1997 Jul; 3(7):452-65. PubMed ID: 9260157
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Analysis of Inflammatory Rheumatoid Synovial Tissues Using Anti-Human Podoplanin Monoclonal Antibody Panel.
Suzuki T; Takakubo Y; Oki H; Liu X; Honma R; Naganuma Y; Goodman SB; Kaneko MK; Kato Y; Takagi M
Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):12-19. PubMed ID: 29377768
[TBL] [Abstract][Full Text] [Related]
10. Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.
Lederman MM; Purvis SF; Walter EI; Carey JT; Medof ME
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4205-9. PubMed ID: 2471198
[TBL] [Abstract][Full Text] [Related]
11. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
[TBL] [Abstract][Full Text] [Related]
12. Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor.
Zhong RK; Kozii R; Ball ED
Br J Haematol; 1995 Oct; 91(2):269-74. PubMed ID: 8547061
[TBL] [Abstract][Full Text] [Related]
13. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
[TBL] [Abstract][Full Text] [Related]
14. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.
Horta MF; Ramalho-Pinto FJ
J Exp Med; 1991 Dec; 174(6):1399-406. PubMed ID: 1720809
[TBL] [Abstract][Full Text] [Related]
15. Proliferation of the synovial lining cell layer in suggested metal hypersensitivity.
Burkandt A; Katzer A; Thaler K; Von Baehr V; Friedrich RE; Rüther W; Amling M; Zustin J
In Vivo; 2011; 25(4):679-86. PubMed ID: 21709014
[TBL] [Abstract][Full Text] [Related]
16. Phagocytic synovial lining cells regulate acute and chronic joint inflammation after antigenic exacerbation of smouldering experimental murine arthritis.
van Lent PL; Holthuysen AE; van Rooijen N; van de Loo FA; van de Putte LB; van den Berg WB
J Rheumatol; 1998 Jun; 25(6):1135-45. PubMed ID: 9632077
[TBL] [Abstract][Full Text] [Related]
17. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.
Medof ME; Walter EI; Rutgers JL; Knowles DM; Nussenzweig V
J Exp Med; 1987 Mar; 165(3):848-64. PubMed ID: 2434600
[TBL] [Abstract][Full Text] [Related]
18. Isolation of decay accelerating factor (DAF) by a two-step procedure and determination of its N-terminal sequence.
Davitz MA; Schlesinger D; Nussenzweig V
J Immunol Methods; 1987 Feb; 97(1):71-6. PubMed ID: 2434569
[TBL] [Abstract][Full Text] [Related]
19. [Immunomorphological characteristics of the synovial membrane in rheumatic diseases].
Radenska-Lopovok SG
Arkh Patol; 2016; 78(4):64-68. PubMed ID: 27600785
[TBL] [Abstract][Full Text] [Related]
20. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.
Konttinen YT; Ceponis A; Meri S; Vuorikoski A; Kortekangas P; Sorsa T; Sukura A; Santavirta S
Ann Rheum Dis; 1996 Dec; 55(12):888-94. PubMed ID: 9014582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
